Literature DB >> 12635171

Specialization of tumour vasculature.

Erkki Ruoslahti1.   

Abstract

Tumour blood vessels express markers that are not present in resting blood vessels of normal tissues, but that can be shared by angiogenic vessels in non-malignant conditions. Many of these proteins are functionally important in the angiogenic process. Some tumours also contain lymphatic vessels, as well as channels that consist of cancer cells and their extracellular matrix. These special features of tumour vessels are good targets for cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12635171     DOI: 10.1038/nrc724

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  185 in total

1.  Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours.

Authors:  Johanne Seguin; Céline Nicolazzi; Nathalie Mignet; Daniel Scherman; Guy G Chabot
Journal:  Tumour Biol       Date:  2012-06-07

2.  Double target for tumor mass destruction.

Authors:  Pipsa Saharinen; Kari Alitalo
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 3.  The evolution of endothelial regulatory paradigms in cancer biology and vascular repair.

Authors:  Joseph W Franses; Elazer R Edelman
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

Review 4.  Applications of molecular imaging.

Authors:  Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  Design of Nanoparticle-Based Carriers for Targeted Drug Delivery.

Authors:  Xiaojiao Yu; Ian Trase; Muqing Ren; Kayla Duval; Xing Guo; Zi Chen
Journal:  J Nanomater       Date:  2016       Impact factor: 2.986

Review 6.  Issues related to targeted delivery of proteins and peptides.

Authors:  Yingjuan Lu; Jun Yang; Emanuela Sega
Journal:  AAPS J       Date:  2006-07-21       Impact factor: 4.009

Review 7.  Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

Review 8.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

9.  Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.

Authors:  Mukund Seshadri; David A Bellnier; Richard T Cheney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-15       Impact factor: 7.038

10.  Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Olivier M Girard; Douglas Hanahan; Robert F Mattrey; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.